Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure
Mohit K. Turagam, Jalaj Garg, William Whang, et al.
Annals of Internal Medicine (2018) Vol. 170, Iss. 1, pp. 41-41
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
José A. Joglar, Mina K. Chung, Anastasia L. Armbruster, et al.
Circulation (2023) Vol. 149, Iss. 1
Open Access | Times Cited: 882
Heart Failure and Atrial Fibrillation, Like Fire and Fury
Matthew A. Carlisle, Marat Fudim, Adam D. DeVore, et al.
JACC Heart Failure (2019) Vol. 7, Iss. 6, pp. 447-456
Open Access | Times Cited: 299
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
José A. Joglar, Mina K. Chung, Anastasia L. Armbruster, et al.
Journal of the American College of Cardiology (2023) Vol. 83, Iss. 1, pp. 109-279
Open Access | Times Cited: 261
Catheter ablation for atrial fibrillation: current indications and evolving technologies
Ramanathan Parameswaran, Ahmed Al‐Kaisey, Jonathan M. Kalman
Nature Reviews Cardiology (2020) Vol. 18, Iss. 3, pp. 210-225
Closed Access | Times Cited: 161
The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation
A. John Camm, Gerald V. Naccarelli, Suneet Mittal, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 19, pp. 1932-1948
Open Access | Times Cited: 127
Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation
Mohit K. Turagam, Daniel Musikantow, William Whang, et al.
JAMA Cardiology (2021) Vol. 6, Iss. 6, pp. 697-697
Open Access | Times Cited: 112
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Emmanuel Ekanem, Petr Neužil, Tobias Reichlin, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 2020-2029
Open Access | Times Cited: 76
Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes
Moh’d Rasheed Abu-Qaoud, Ashish Kumar, Tushar Tarun, et al.
JACC. Clinical electrophysiology (2023) Vol. 9, Iss. 10, pp. 2109-2118
Open Access | Times Cited: 46
Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data
Shaojie Chen, Helmut Pürerfellner, Christian Meyer, et al.
European Heart Journal (2019) Vol. 41, Iss. 30, pp. 2863-2873
Closed Access | Times Cited: 130
Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure
Ambarish Pandey, Muthiah Vaduganathan, Sameer Arora, et al.
Circulation (2020) Vol. 142, Iss. 3, pp. 230-243
Open Access | Times Cited: 74
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial
Derek S. Chew, Yanhong Li, Patricia A. Cowper, et al.
Circulation (2022) Vol. 146, Iss. 7, pp. 535-547
Open Access | Times Cited: 46
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices
Derek S. Chew, Zhen Li, Benjamin A. Steinberg, et al.
Circulation Arrhythmia and Electrophysiology (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 44
JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias
Akihiko Nogami, Takashi Kurita, Kengo Kusano, et al.
Circulation Journal (2022) Vol. 86, Iss. 2, pp. 337-363
Open Access | Times Cited: 38
Italian Registry in the Setting of Atrial Fibrillation Ablation with Rivaroxaban - IRIS
Carlo Lavalle, Nicola Pierucci, Marco Valerio Mariani, et al.
Minerva Cardiology and Angiology (2024) Vol. 72, Iss. 6
Closed Access | Times Cited: 11
Catheter ablation versus medical therapy for atrial fibrillation in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis
Elísio Bulhões, Vânio Antunes, Roberto Mazetto, et al.
Heart Rhythm (2024) Vol. 21, Iss. 9, pp. 1595-1603
Closed Access | Times Cited: 8
Association Between Atrial Fibrillation and Sudden Cardiac Death
Victor Waldmann, Xavier Jouven, Kumar Narayanan, et al.
Circulation Research (2020) Vol. 127, Iss. 2, pp. 301-309
Open Access | Times Cited: 62
Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices
Benjamin A. Steinberg, Zhen Li, Emily C. O’Brien, et al.
Heart Rhythm (2021) Vol. 18, Iss. 5, pp. 709-716
Open Access | Times Cited: 54
Cost-Effectiveness of Comprehensive Quadruple Therapy for Heart Failure With Reduced Ejection Fraction
Neal M. Dixit, Neil U. Parikh, Boback Ziaeian, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 5, pp. 541-551
Open Access | Times Cited: 21
Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk
Mingxiao Li, Lan Ren, Liu He, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 20, pp. 1957-1969
Closed Access | Times Cited: 6
Safety and Effectiveness of Pulsed Field Ablation for Atrial Fibrillation in Patients With Heart Failure
Mohit K. Turagam, Petr Neužil, Boris Schmidt, et al.
JACC. Clinical electrophysiology (2024) Vol. 10, Iss. 7, pp. 1675-1686
Closed Access | Times Cited: 6
Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure
Shilpkumar Arora, Rahul Jaswaney, Chinmay Jani, et al.
The American Journal of Cardiology (2020) Vol. 137, pp. 45-54
Closed Access | Times Cited: 43
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions
Grigorios Tsigkas, Anastasiοs Apostolos, Stefanos Despotopoulos, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 4, pp. 1201-1210
Closed Access | Times Cited: 33
JCS/JHRS 2021 guideline focused update on non‐pharmacotherapy of cardiac arrhythmias
Akihiko Nogami, Takashi Kurita, Kengo Kusano, et al.
Journal of Arrhythmia (2022) Vol. 38, Iss. 1, pp. 1-30
Open Access | Times Cited: 24
Coronary Artery Injury Related to Catheter Ablation for Cardiac Arrhythmias ― A Systematic Review ―
Kanae Hasegawa, Hiroshi Tada
Circulation Journal (2025)
Closed Access
Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation
Jorge Romero, Roberto Cerrud‐Rodriguez, Isabella Alviz, et al.
JACC. Clinical electrophysiology (2019) Vol. 5, Iss. 12, pp. 1396-1405
Closed Access | Times Cited: 35
Page 1 - Next Page

Scroll to top